Fatal graft-versus-host disease following adult-to-adult living donor liver transplantation from an HLA nonhomozygous donor

Young-Dong Yu, Dong-Sik Kim, Neul Ha, Sung Won Jung, Jae Hyun Han, Joo Young Kim, Sung Hwan Park, Yunjung Cho

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The use of a human leukocyte antigen (HLA) homozygous donor to a haploidentical recipient is a well-documented cause of transfusion-associated graft-versus-host disease (GVHD). Several authors have reported that use of a graft from an HLA-homozygous donor with 1-way donor-recipient HLA matching led to an extremely high risk of developing GVHD in LDLT. We have experienced a fatal case of acute GVHD following adult-to-adult LDLT from a donor who was heterozygous at a single HLA locus. A 53-year-old female underwent LDLT for chronic hepatitis B and recurrent hepatocellular carcinoma. The donor was her 23-year-old son. The HLA phenotype of the donor was not homozygous (A24, -; B54, -; DR4, 9) and revealed one-way donor-dominant HLA matching at two loci with the recipient (A2, 24; B48, 54; DR4, 12). On the fortieth postoperative day, the patient showed erythematous skin lesions. Skin biopsy revealed typical findings of GVHD. Donor-derived chimerism was demonstrated by performing fluorescent in situ hybridization (FISH) using the recipient's skin tissue. As the clinical course deteriorated, etanercept was started in addition to broad-spectrum antibiotics but there was no improvement. As multi-organ failure progressed, the patient succumbed to death on the 54th postoperative day, which was 2 weeks after onset of GVHD. The prevention of GVHD is more important since the results of treatment have been disappointing. We have experienced a fatal case of acute GVHD following adult-to-adult LDLT from a HLA non-homozygous donor. HLA heterozygosity at a single locus does not preclude the possibility of developing GVHD following adult-to-adult LDLT.

Original languageEnglish
Pages (from-to)394-396
Number of pages3
JournalProgress in Transplantation
Volume26
Issue number4
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Living Donors
Graft vs Host Disease
HLA Antigens
Liver Transplantation
Tissue Donors
Skin
Chimerism
Chronic Hepatitis B
Fluorescence In Situ Hybridization
Nuclear Family
varespladib methyl
Hepatocellular Carcinoma
Anti-Bacterial Agents
Transplants
Phenotype
Biopsy

Keywords

  • Graft-versus-host disease
  • Human leukocyte antigen
  • Living donor liver transplantation
  • Nonhomozygous
  • Related body regions
  • Transplant donor

ASJC Scopus subject areas

  • Transplantation

Cite this

Fatal graft-versus-host disease following adult-to-adult living donor liver transplantation from an HLA nonhomozygous donor. / Yu, Young-Dong; Kim, Dong-Sik; Ha, Neul; Jung, Sung Won; Han, Jae Hyun; Kim, Joo Young; Park, Sung Hwan; Cho, Yunjung.

In: Progress in Transplantation, Vol. 26, No. 4, 01.01.2016, p. 394-396.

Research output: Contribution to journalArticle

@article{60ebfd7da96642f7bbeb21f2aa502866,
title = "Fatal graft-versus-host disease following adult-to-adult living donor liver transplantation from an HLA nonhomozygous donor",
abstract = "The use of a human leukocyte antigen (HLA) homozygous donor to a haploidentical recipient is a well-documented cause of transfusion-associated graft-versus-host disease (GVHD). Several authors have reported that use of a graft from an HLA-homozygous donor with 1-way donor-recipient HLA matching led to an extremely high risk of developing GVHD in LDLT. We have experienced a fatal case of acute GVHD following adult-to-adult LDLT from a donor who was heterozygous at a single HLA locus. A 53-year-old female underwent LDLT for chronic hepatitis B and recurrent hepatocellular carcinoma. The donor was her 23-year-old son. The HLA phenotype of the donor was not homozygous (A24, -; B54, -; DR4, 9) and revealed one-way donor-dominant HLA matching at two loci with the recipient (A2, 24; B48, 54; DR4, 12). On the fortieth postoperative day, the patient showed erythematous skin lesions. Skin biopsy revealed typical findings of GVHD. Donor-derived chimerism was demonstrated by performing fluorescent in situ hybridization (FISH) using the recipient's skin tissue. As the clinical course deteriorated, etanercept was started in addition to broad-spectrum antibiotics but there was no improvement. As multi-organ failure progressed, the patient succumbed to death on the 54th postoperative day, which was 2 weeks after onset of GVHD. The prevention of GVHD is more important since the results of treatment have been disappointing. We have experienced a fatal case of acute GVHD following adult-to-adult LDLT from a HLA non-homozygous donor. HLA heterozygosity at a single locus does not preclude the possibility of developing GVHD following adult-to-adult LDLT.",
keywords = "Graft-versus-host disease, Human leukocyte antigen, Living donor liver transplantation, Nonhomozygous, Related body regions, Transplant donor",
author = "Young-Dong Yu and Dong-Sik Kim and Neul Ha and Jung, {Sung Won} and Han, {Jae Hyun} and Kim, {Joo Young} and Park, {Sung Hwan} and Yunjung Cho",
year = "2016",
month = "1",
day = "1",
doi = "10.1177/1526924816664087",
language = "English",
volume = "26",
pages = "394--396",
journal = "Progress in Transplantation",
issn = "1526-9248",
publisher = "InnoVision Communications",
number = "4",

}

TY - JOUR

T1 - Fatal graft-versus-host disease following adult-to-adult living donor liver transplantation from an HLA nonhomozygous donor

AU - Yu, Young-Dong

AU - Kim, Dong-Sik

AU - Ha, Neul

AU - Jung, Sung Won

AU - Han, Jae Hyun

AU - Kim, Joo Young

AU - Park, Sung Hwan

AU - Cho, Yunjung

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The use of a human leukocyte antigen (HLA) homozygous donor to a haploidentical recipient is a well-documented cause of transfusion-associated graft-versus-host disease (GVHD). Several authors have reported that use of a graft from an HLA-homozygous donor with 1-way donor-recipient HLA matching led to an extremely high risk of developing GVHD in LDLT. We have experienced a fatal case of acute GVHD following adult-to-adult LDLT from a donor who was heterozygous at a single HLA locus. A 53-year-old female underwent LDLT for chronic hepatitis B and recurrent hepatocellular carcinoma. The donor was her 23-year-old son. The HLA phenotype of the donor was not homozygous (A24, -; B54, -; DR4, 9) and revealed one-way donor-dominant HLA matching at two loci with the recipient (A2, 24; B48, 54; DR4, 12). On the fortieth postoperative day, the patient showed erythematous skin lesions. Skin biopsy revealed typical findings of GVHD. Donor-derived chimerism was demonstrated by performing fluorescent in situ hybridization (FISH) using the recipient's skin tissue. As the clinical course deteriorated, etanercept was started in addition to broad-spectrum antibiotics but there was no improvement. As multi-organ failure progressed, the patient succumbed to death on the 54th postoperative day, which was 2 weeks after onset of GVHD. The prevention of GVHD is more important since the results of treatment have been disappointing. We have experienced a fatal case of acute GVHD following adult-to-adult LDLT from a HLA non-homozygous donor. HLA heterozygosity at a single locus does not preclude the possibility of developing GVHD following adult-to-adult LDLT.

AB - The use of a human leukocyte antigen (HLA) homozygous donor to a haploidentical recipient is a well-documented cause of transfusion-associated graft-versus-host disease (GVHD). Several authors have reported that use of a graft from an HLA-homozygous donor with 1-way donor-recipient HLA matching led to an extremely high risk of developing GVHD in LDLT. We have experienced a fatal case of acute GVHD following adult-to-adult LDLT from a donor who was heterozygous at a single HLA locus. A 53-year-old female underwent LDLT for chronic hepatitis B and recurrent hepatocellular carcinoma. The donor was her 23-year-old son. The HLA phenotype of the donor was not homozygous (A24, -; B54, -; DR4, 9) and revealed one-way donor-dominant HLA matching at two loci with the recipient (A2, 24; B48, 54; DR4, 12). On the fortieth postoperative day, the patient showed erythematous skin lesions. Skin biopsy revealed typical findings of GVHD. Donor-derived chimerism was demonstrated by performing fluorescent in situ hybridization (FISH) using the recipient's skin tissue. As the clinical course deteriorated, etanercept was started in addition to broad-spectrum antibiotics but there was no improvement. As multi-organ failure progressed, the patient succumbed to death on the 54th postoperative day, which was 2 weeks after onset of GVHD. The prevention of GVHD is more important since the results of treatment have been disappointing. We have experienced a fatal case of acute GVHD following adult-to-adult LDLT from a HLA non-homozygous donor. HLA heterozygosity at a single locus does not preclude the possibility of developing GVHD following adult-to-adult LDLT.

KW - Graft-versus-host disease

KW - Human leukocyte antigen

KW - Living donor liver transplantation

KW - Nonhomozygous

KW - Related body regions

KW - Transplant donor

UR - http://www.scopus.com/inward/record.url?scp=85014310748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014310748&partnerID=8YFLogxK

U2 - 10.1177/1526924816664087

DO - 10.1177/1526924816664087

M3 - Article

C2 - 27555077

AN - SCOPUS:85014310748

VL - 26

SP - 394

EP - 396

JO - Progress in Transplantation

JF - Progress in Transplantation

SN - 1526-9248

IS - 4

ER -